Related Experiment Videos
Colistin versus colistin plus meropenem for severe infections Authors' reply
Mical Paul1, Yehuda Carmeli2, George L Daikos3
1Institute of Infectious Diseases, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3109601, Israel.
The Lancet. Infectious Diseases
|April 27, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Internists facing emerging arboviral diseases: time to get prepared.
Internal and emergency medicine·2026
Gram-negative bacterial infection randomized controlled trials (RCTs) in the 21st century: characteristics and evolution.
JAC-antimicrobial resistance·2026
Metabolic-dysfunction associated steatotic liver disease: clinical features and noninvasive methods of detection in young adults with obesity.
European journal of gastroenterology & hepatology·2026
Evaluating the impact of antiviral post-exposure prophylaxis for health-care workers during orthoebolavirus outbreaks: a modelling study.
The Lancet. Infectious diseases·2026
Finerenone Alleviates Cardiac Microvascular Injury and Neutrophil Extracellular Traps Formation in Diabetic Cardiomyopathy via Regulating AKT1 Phosphorylation.
Acta physiologica (Oxford, England)·2026
Genomic epidemiology of Streptococcus pyogenes across multiple centres in China.
Journal of infection and public health·2026
Research progress of lipoarabinomannan in the diagnosis of mycobacterium tuberculosis: diagnostic potential and new highlights of quantum dot technology.
Diagnostic microbiology and infectious disease·2026